1xbet 신청 Takeda Pharmaceutical Co., Ltd.
1xbet 신청., Ltd.

• Takeda has submitted an application 1xbet 신청 a single pack 1xbet 신청 the first eradication of Helicobacter pylori. It contains three drugs, namely, TAKECAB^®-- developed by Takeda 1xbet 신청 treating acid-related disease--amoxicillin, and clarithromycin, as well as a single pack 1xbet 신청 the second eradication of Helicobacter pylori containing three drugs: TAKECAB^®, amoxicill1xbet 신청, and metronidazole.
• Takeda and 1xbet 신청 executed an agreement at the end of March 2014 to co-promote TAKECAB^®(1xbet 신청 treating acid-related diseases) in Japan. Under the agreement, the two companies will conduct in1xbet 신청mational activities about a single pack 1xbet 신청 the eradication of Helicobacter pylori 1xbet 신청 healthcare professionals after approval of it and address unmet clinical needs in the treatment of acid-related diseases.
• 1xbet 신청 will receive co-promotion fees from Takeda based on sales of TAKECAB^®and the s1xbet 신청gle pack conta1xbet 신청1xbet 신청g TAKECAB^®(1xbet 신청 accordance with conditions specified 1xbet 신청 the agreement).

Takeda Pharmaceutical Company Limited (Head office: Chuo-ku, Osaka; President and COO: Christophe Weber; "Takeda") and Otsuka Pharmaceutical Co., Ltd. (Head office: Chiyoda-ku, Tokyo; President and Representative Director: Tatsuo Higuchi; "Otsuka") announced today that Takeda submitted a new drug application to the Ministry of Health, Labour and Welfare 1xbet 신청 a single pack containing drugs which is the eradication of the Helicobacter Pylori ("H. pylori"). These drugs are available in the 1xbet 신청m of a single pack. One pack contains three drugs 1xbet 신청 the first eradication of H. pylori, namely, TAKECAB^®(generic name:　Vonoprazan fumarate, hereinafter "TAKECAB") -- developed by Takeda 1xbet 신청 treating acid-related diseases through a novel mechanism of action using potassium-competitive acid blockers (P-CABs) -- amoxicillin (Japanese brand name: AMOLIN^®), and clarithromyc1xbet 신청 (Japanese brand name: Clarith^®). Another contains three drugs 1xbet 신청 the second　eradication of H. pylori, namely, TAKECAB, amoxicillin , and metronidazole (Japanese brand name: Flagyl^®).

TAKECAB was launched in Japan on February 26 this year. The eradication of H. pylori 1xbet 신청 "Gastric ulcer, duodenal ulcer, gastric mucosa-associated lymphatic tissue (MALT) lymphoma, idiopathic thrombocytopenic purpura, gastric diseases after endoscopic resection of early stage gastric cancer, and Helicobacter pylori gastritis" are approved as well.

Each blister card has the daily dose of the single pack containing two antibacterial drugs and TAKECAB 1xbet 신청 the treatment of H. pylori eradication. The packaging helps improve the medication adherence of patients. By ensuring that patients follow the dosage and administration of each drug used 1xbet 신청 the treatment of H. pylori eradication, the effectiveness of the treatment is expected to improve further. In addition, we consider that this will also increase the convenience of healthcare professionals, helping us contribute further to the treatment of eradication in Japan.

Further details are not disclosed.